Treating depression can be a slow process. Even after pinpointing the correct medication, it can still take weeks to take effect. Abraham A. Palmer, PhD, Professor and Vice Chair for Basic Research in the Department of Psychiatry at UC San Diego joins our host Dr. David Granet to discuss his work uncovering of the molecular and cellular underpinnings of depression. Dr. Palmer and his team are exploring how inhibiting the Glyoxalase 1 (GLO1) enzyme can reduce signs of depression. He explains the science behind the discovery and the implications for new, faster-acting treatments.

Series: "Health Matters" [Health and Medicine] [Science] [Show ID: 32383]